Sanara Medtech Inc reports results for the quarter ended in March - Earnings Summary

Sanara MedTech

13/05/2024 22:02

* Sanara Medtech Inc  SMTI.OQ  reported a quarterly adjusted
loss
of 21 cents​​ per share for the quarter ended in March, lower
than the same quarter last year, when the company reported EPS
of -14 cents.  The lone analyst forecast for the quarter was
for a loss of 7 cents per share. 
    * Revenue rose 19.4% to $18.54 million from a year ago;
analysts
expected $18.50 million. 
    * Sanara Medtech Inc's reported EPS for the quarter was a
loss
of 21 cents​.
    * The company reported a quarterly loss of $1.76 million.
    * Sanara Medtech Inc shares had fallen by 15.1% this
quarter and
lost 23.6% so far this year.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Sanara Medtech
Inc is $44.00 
This summary was machine generated from LSEG data May 13 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.07          -0.21          Missed
 Dec. 31 2023      -0.13          -0.03          Beat
 Sep. 30 2023      0.00           -0.13          Missed
 Jun. 30 2023      -0.13          -0.22          Missed